What you need to know about Ark Invest, an active ETF firm led by Cathie Wood that invests in disruptive, high-growth tech ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...

CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...

Prime Medicine has surged over 130% in three months, driven by pipeline progress and visibility from recent scientific ...

ARK Invest isn’t letting go of its crypto conviction. Fresh filings reveal that the fund scooped another $8.2M worth of ...

Olga Berson of Thompson Coburn LLP discusses opportunities as well as intellectual property pitfalls for sovereign wealth ...

Fintel reports that on September 18, 2025, JP Morgan initiated coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $60.62, marking a -2.38% move from the previous day.

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds ...

Crispr Therapeutics AG ( ($CRSP) ) has risen by 7.75%. Read on to learn why. Crispr Therapeutics AG has experienced a notable 7.75% increase in ...

This year’s WIRED Health summit in Boston featured Moderna CEO Stéphane Bancel, CNN chief medical correspondent Sanjay Gupta, ...